0000899866-20-000035.txt : 20200331
0000899866-20-000035.hdr.sgml : 20200331
20200331170422
ACCESSION NUMBER: 0000899866-20-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200330
FILED AS OF DATE: 20200331
DATE AS OF CHANGE: 20200331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANTSON LUDWIG
CENTRAL INDEX KEY: 0001491435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 20762635
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS, INC
STREET 2: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_158568864459640.xml
FORM 4
X0306
4
2020-03-30
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001491435
HANTSON LUDWIG
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BLVD
BOSTON
MA
02210
1
1
0
0
CEO
Common Stock, par value $.0001 per share
2020-03-30
4
F
0
3202
85.43
D
190658
D
This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
/s/ Douglas Barry, Attorney-in-Fact for Ludwig Hantson
2020-03-31